Clinical Decision Support Tool for Pre-emptive Screening of Alzheimer’s Disease
Implementing Organization
About
The product will be essentially an AI -based holistic risk prediction platform for early stage Alzheimer’s disease detection. Product incorporates two separate component- a) A salivary Lactoferrin (biomarker) detection kit & b) AI-based risk propensity prediction platform
Acces sibility Controls